Managerial accounting assignment. In order to sustain the growth and future of Demola, steps are being taken to integrate innovation projects into the core university course structure. These include offering dedicated Demola courses, integrated into the curriculum, thus offering students from all local universities the chance to work in multi-disciplinary teams with support from professors and industry professionals. The New Factory concept helps to ensure that results and products created in Demola will have a path for continuation and development into business-creating concepts. Furthermore, national and international networks are being created to both generate talent flows between regions and to create maximum value for the players involved and partner companies.

Question 61 I want to ask something about cerebrovascular accident (CVA). Can you please tell me how we can rapidly pinpoint the exact anatomical site of the neurological deficit using physical findings in the emergency room?

Question 62 Why do you treat dissection of the carotid artery with an anticoagulant in the acute management of stroke secondary to dissection? To me this seems paradoxical as it would increase the severity of dissection.

Question 63 Last week, in a neurology viva, I was asked about the indications for heparinization in patients with a stroke. I want to know when I can stop heparin and what test I should use for assessing its therapeutic range.

Question 64 Has heparin a role in the management of acute ischaemic stroke not accompanied by atrial fibrillation?

Question 65 1. In the treatment of a stroke, does low-molecular-weight heparin (LMWH) have an advantage over heparin? 2. In an ischaemic stroke in evolution, for how long should heparin be administered?

Question 66 Can streptokinase be used in acute cerebral infarction and, if so, what is the dose?

Question 67 There seems now to be a consensus about starting aspirin therapy in acute ischaemic strokes as early as possible. Why has this changed from past recommendations to avoid aspirin early (during the first 48 hours) during the ischaemic stroke on the pretext that it could convert an ischaemic infarct into a haemorrhagic one, thus increasing the dangers of complications like cerebral oedema and raised intracranial pressure? If both opinions are based on clinical trials, what is the significance of the much hyped 'evidence-based medicine'?

Question 68 I understand that a loading dose of clopidogrel 600-900 mg can be given to ischaemic stroke in evolution and can stop the evolving deficit. Would you agree?

Question 69 Is there any rationale for giving patients with recurrent strokes a combination of aspirin and anticoagulant?

Question 70 1. Does a dipyridamol-aspirin combination have any superiority over aspirin alone in the secondary prevention of a stroke? 2. Is an aspirin plus anticoagulant combination superior to a dipyridamol aspirin combination in the treatment of recurrent ischaemic stroke not controlled by aspirin alone?